People
A partner in our Finance & Restructuring practice, Delphine assists French and international clients on bank financing, acquisition financing, LBO financing, real estate financing and debt restructuring transactions.
Delphine Guillotte is a Finance & Restructuring partner based in King & Spalding’s Paris office. Delphine provides strategic legal advice to both French and international clients on a broad spectrum of banking and finance matters. Her practice encompasses areas such as bank financing, acquisition financing, leveraged buyout (LBO) financing, real estate financing, and debt restructuring, with a particular focus on complex and cross-border transactions.
Prior to joining King & Spalding, Delphine held senior roles at Bredin Prat and Gide Loyrette Nouel.
Delphine is admitted to the Paris Bar and holds a PhD in private law, a postgraduate degree (DESS) in the Law of Financial Products and Markets from the University of Paris 11 (now Paris-Saclay), in partnership with ESCP-EAP business school and a Sciences Po Rennes degree.
Private Law (PhD), Université Paris XI (Université Paris-Saclay)
Law of Financial Products and Markets (Postgraduate), Université Paris XI (Université Paris-Saclay), EAP-ESCP Business School
Diplôma, Science Po Rennes
Paris
Paris Bar
French
September 19, 2025
Leaders League Recognizes King & Spalding Practices Among the Leaders in France
August 7, 2025
K&S advises Oxford Biomedica PLC on its $125M secured loan facility provided by Oaktree Capital Management
August 1, 2025
King & Spalding advises Oxford Biomedica PLC on $125m secured financing package
September 19, 2025
Leaders League Recognizes King & Spalding Practices Among the Leaders in France
August 7, 2025
K&S advises Oxford Biomedica PLC on its $125M secured loan facility provided by Oaktree Capital Management
August 1, 2025
King & Spalding advises Oxford Biomedica PLC on $125m secured financing package
September 19, 2025
Leaders League Recognizes King & Spalding Practices Among the Leaders in France
August 7, 2025
K&S advises Oxford Biomedica PLC on its $125M secured loan facility provided by Oaktree Capital Management
August 1, 2025
King & Spalding advises Oxford Biomedica PLC on $125m secured financing package
Private Law (PhD), Université Paris XI (Université Paris-Saclay)
Law of Financial Products and Markets (Postgraduate), Université Paris XI (Université Paris-Saclay), EAP-ESCP Business School
Diplôma, Science Po Rennes
Paris
Paris Bar
French